Rubicon OrganicsROMJF 50 Cash Ratio is 0.24 as of Mar. 2026, which is 68% below its 10-year median of 0.74. GuruFocus rates ROMJF with a GF Score™ of 50/100 and a GF Value™ of $0.38 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 973 Drug Manufacturers companies, Rubicon Organics ranks worse than 71.74% on this metric.
Rubicon Organics has a Cash Ratio of 0.24. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Rubicon Organics's Cash Ratio or its related term are showing as below:
ROMJF'
s Cash Ratio Range Over the Past 10 Years
Min: 0.07 Med: 0.74 Max: 3.99
Current: 0.24
During the past 10 years, Rubicon Organics's highest Cash Ratio was 3.99. The lowest was 0.07. And the median was 0.74.
ROMJF's Cash Ratio is ranked worse than 71.74% of 973
companies
in the Drug Manufacturers industry
Industry Median: 0.61
vs ROMJF: 0.24
Rubicon Organics (OTCPK:ROMJF) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Rubicon Organics Cash Ratio Related Terms
Rubicon Organics Cash Ratio Historical Data
* Premium members only.
The historical data trend for Rubicon Organics's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Rubicon Organics's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rubicon Organics Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rubicon Organics's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Rubicon Organics's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rubicon Organics (ROMJF) has a Cash Ratio of 0.24 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Rubicon Organics and its competitors. This is 68% below median its historical median of 0.74. Over the past decade, Rubicon Organics' Cash Ratio has ranged from 0.07 to 3.99. According to the industry distribution chart, Rubicon Organics ranks #698 out of 973 companies in the Drug Manufacturers industry, placing it in the top 71.7%.
Is Rubicon Organics' Cash Ratio too high?
Rubicon Organics' current Cash Ratio of 0.24 is 68% below median its 10-year median of 0.74. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 3.99. The Drug Manufacturers industry median Cash Ratio is 0.61. Rubicon Organics' value of 0.24 is 60.7% below this industry median. Based on the distribution chart, Rubicon Organics ranks #698 out of 973 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Rubicon Organics has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rubicon Organics' Cash Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Rubicon Organics ranks #698 out of 973 companies for Cash Ratio. This places Rubicon Organics in the lower half of its industry. The industry median Cash Ratio is 0.61. Rubicon Organics' value of 0.24 is 60.7% below this benchmark. Historically, Rubicon Organics' own Cash Ratio has ranged from 0.07 to 3.99 over the past decade. While the company's 10-year median is 0.74 vs. the industry median of 0.61, Rubicon Organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.61, based on 973 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rubicon Organics's current Cash Ratio of 0.24 is 60.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Rubicon Organics and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rubicon Organics's current Cash Ratio is 0.24, which is 68% below median its own 10-year median of 0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rubicon Organics stock overvalued right now?
Based on GuruFocus' analysis, Rubicon Organics (ROMJF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.38, compared to a current price of $0.33 — trading 13.2% below its estimated fair value. The current Cash Ratio is 0.24, which is 68% below median its 10-year median of 0.74 and 60.7% below the Drug Manufacturers industry median of 0.61. Rubicon Organics' overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Rubicon Organics (ROMJF), the current Cash Ratio is 0.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rubicon Organics (ROMJF) Overvalued in 2026?
Based on GuruFocus' analysis, Rubicon Organics stock appears to be undervalued.
The current stock price of $0.33 is trading 13.2% below its estimated GF Value™ of $0.38.
GuruFocus considers Rubicon Organics to be Modestly Undervalued.
Key valuation signals for ROMJF:
Cash Ratio: 0.24 (68% below median its 10-year median of 0.74)
GF Value™: $0.38 vs. price of $0.33 (13.2% below fair value)
Industry Position: 60.7% below the Drug Manufacturers median (#698 of 973)
No single metric tells the full story. See the ROMJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rubicon Organics Inc is engaged in the production and sale of cannabis in Canada. The company produces and processes organic cannabis at its wholly owned, federally licensed 125,000 square foot facility in Delta, British Columbia which it sells under its wholly owned brands and certain wholesale channels. Its brands include Simply Bare, 1964 Supply Co, Wildflower, and Homestead Cannabis Supply. It operates in a single reportable segment, being the production and sale of cannabis in Canada.
50GF Score
Get the complete analysis for ROMJF
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROMJF has been successfully added to your 
